netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Natalizumab found 5 matches
Open monograph to display formulary status BNF Category
  Natalizumab Malignant disease and immunosuppression - Natalizumab - 08.02.04
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section MHRA Drug Safety Update (Apr 2016): Natalizumab (Tysabri▼): progressive multifocal leukoencephalopathy— updated advice to support early detection (08.02.04)
link in drug section MHRA Drug Safety Update (May 2011): Natalizumab (Tysabri▼): risk of progressive multifocal leukoencephalopathy is increased in patients who have had previous immunosuppressant treatment (08.02.04)
link in drug section NICE TA127: Natalizumab for the treatment of adults with highly active relapsing–remitting multiple sclerosis (08.02.04)

SubSection Titles / notes  
Natalizumab - (08.02.04)

 
netFormulary